BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20473733)

  • 21. Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a systematic review with meta-analysis.
    Ma L; Wang B; Long Y; Li H
    Front Med; 2017 Jun; 11(2):191-202. PubMed ID: 28349301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Traditional Chinese medicine plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.
    Meng MB; Cui YL; Guan YS; Ying Z; Zheng MH; Yuan CK; Zhang RM
    J Altern Complement Med; 2008 Oct; 14(8):1027-42. PubMed ID: 18990050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma.
    Xiang X; Zhong JH; Wang YY; You XM; Ma L; Xiang BD; Li LQ
    Clin Transl Oncol; 2017 Jul; 19(7):891-897. PubMed ID: 28160206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma.
    Zhong C; Guo RP; Li JQ; Shi M; Wei W; Chen MS; Zhang YQ
    J Cancer Res Clin Oncol; 2009 Oct; 135(10):1437-45. PubMed ID: 19408012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
    Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transarterial chemoembolization combined with Huaier granule for the treatment of primary hepatic carcinoma: Safety and efficacy.
    Zhao GS; Liu Y; Zhang Q; Li C; Zhang YW; Ren ZZ; Zhou J; Zhang M
    Medicine (Baltimore); 2017 Jul; 96(29):e7589. PubMed ID: 28723799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial.
    Shi M; Lu LG; Fang WQ; Guo RP; Chen MS; Li Y; Luo J; Xu L; Zou RH; Lin XJ; Zhang YQ
    J Natl Cancer Inst; 2013 Jan; 105(1):59-68. PubMed ID: 23150720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine.
    Zhou LY; Shan ZZ; You JL
    Chin J Integr Med; 2009 Apr; 15(2):107-11. PubMed ID: 19407947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transarterial chemoembolization combined with Jie-du granule preparation improves the survival outcomes of patients with unresectable hepatocellular carcinoma.
    Zhao H; Zhai X; Chen Z; Wan X; Chen L; Shen F; Ling C
    Oncotarget; 2017 Jul; 8(28):45234-45241. PubMed ID: 28423370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical study on treatment of advanced non-small-cell lung cancer with Chinese herbal medicine in different stages combined with chemotherapy].
    Xu ZY; Jin CJ; Shen DY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Oct; 27(10):874-8. PubMed ID: 17990450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective controlled analysis of outcomes of using integrated therapy of traditional Chinese and modern medicines for primary liver cancer of middle and late stages.
    Chen Z; Li B; Yue X; Zhu D; Yu C; Wu M; Ling C
    J Altern Complement Med; 2006 Dec; 12(10):941-2. PubMed ID: 17212565
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapeutic effect of Jianpi Liqi Fang combined with transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and spleen deficiency syndrome.
    Chen X; Wang P; Yang M; Zhou W; Chen J; Meng Z; Su S
    J Tradit Chin Med; 2021 Feb; 41(1):157-166. PubMed ID: 33522209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trans-arterial p53-gene-embolization with gelatin sponge microparticles for hepatocellular carcinoma with BCLC stage B: single-center experience.
    Liu Y; Zhang Y; Bautista D; Tang S; Zhou J; Li C; Zhao G
    Cell Biochem Biophys; 2015 Jan; 71(1):99-104. PubMed ID: 25323562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
    Yuan P; Zhang Z; Kuai J
    J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Randomized Clinical Trial.
    Yoon SM; Ryoo BY; Lee SJ; Kim JH; Shin JH; An JH; Lee HC; Lim YS
    JAMA Oncol; 2018 May; 4(5):661-669. PubMed ID: 29543938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial.
    Cheng BQ; Jia CQ; Liu CT; Fan W; Wang QL; Zhang ZL; Yi CH
    JAMA; 2008 Apr; 299(14):1669-77. PubMed ID: 18398079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arsenic trioxide combined with transarterial chemoembolization for unresectable primary hepatic carcinoma: A systematic review and meta-analysis.
    Song P; Hai Y; Ma W; Zhao L; Wang X; Xie Q; Li Y; Wu Z; Li Y; Li H
    Medicine (Baltimore); 2018 May; 97(18):e0613. PubMed ID: 29718867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial.
    Liu B; Huang JW; Li Y; Hu BS; He X; Zhao W; Zheng YB; Lu LG
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1103-8. PubMed ID: 25504506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Survival time of advanced gastric cancer patients treated with integrated traditional Chinese and Western medicine therapy].
    Cao ND; Zhao AG; Yang JK
    Zhong Xi Yi Jie He Xue Bao; 2010 Feb; 8(2):116-20. PubMed ID: 20141732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.